Gadolinium - A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1104-1108

  Grobner, Thomas ^a  

^a General Hospital Wiener Neustadt   (Austria)

Author keywords

End stage renal disease; Gadolinium DTPA; Metabolic acidosis; Nephrogenic fibrosing dermopathy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY FIBROSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEPHROGENIC FIBROSING DERMOPATHY; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SKIN DEFECT;

ADULT; AGED; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; SKIN DISEASES;

EID: 33645289942     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfk062     Document Type: Article

References (21)

1. Cowper SE, Su L, Robin H, Bhawan J, LeBoit PE. Nephrogenic fibrosing dermopathy. Am J Dermatopathol 2001; 23: 383-393
2. Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD. Nephrogenic fibrosing dermopathy: A novel cutaneous fibrosing disorder in patients with renal failure. Am J Med 2003; 114: 563-572
3. Cowper SE. Nephrogenic fibrosing dermopathy: The first six Years. Curr Opin Rheumatol 2003; 15: 785-790
4. Leboit PE. What nephrogenic fibrosing dermopathy might be. Arch Dermatol 2003; 139: 928-930
5. Ting WW, Stone MS, Madison KC, Kurtz K. Nephrogenic fibrosing dermopathy with systemic involvement. Arch Dermatol 2003; 139: 903-906
6. Daram SR, Cortese CM, Bastani B. Nephrogenic fibrosing dermopathy/ nephrogenic systemic fibrosis: Report of a new case with literature review. Am J Kidney Dis 2005; 46: 754-759
7. McNeill AM, Barr RJ. Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis. Int J Dermatol 2002; 41: 364-367
8. Joffe P, Thomsen HS, Meusel M. Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad Radiol 1998; 5: 491-502
9. Mann JS. Stability of gadolinium complexes in vitro and in vivo. J Comput Assist Tomogr 1993; 17: S19-S23
10. Vorobiov M, Basok A, Tovbin D, Shnaider A, Katchko L, Rogachev B. Iron-mobilizing properties of the gadolinium - DTPA complex: Clinical and experimental observations. Nephrol Dial Transplant 2003; 18: 884-887
11. Jimenez SA, Artlett CM, Sandorfi N et al. Nephrogenic fibrosing dermopathy: Study of inflammatory cells and transforming growth factor beta1 expression in affected skin. Arthritis Rheum 2004; 50: 2660-2666
12. Cowper SE, Bucala R. Nephrogenic fibrosing dermopathy: Suspect identified, Motive Unclear. [Letter]. Am J Dermatopathol 2003; 25: 358
13. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: Collagen - secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36: 598-606
14. Mackay-Wiggan JM, Cohen DJ, Hardy MA, Knobler EH, Grossman ME. Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). Am Acad Dermatol 2003; 48: 55-60
15. Fazeli A, Lio PA, Liu V. Nephrogenic fibrosing dermopathy: Are ACE inhibitors the missing link? [Letter]. Arch Dermatol 2004; 140: 1401
16. Cowper SE. Nephrogenic systemic fibrosis: The nosological and conceptual evolution of nephrogenic fibrosing dermopathy. Am J Kidney Dis 2005; 46: 763-765
17. Baron PW, Cantos K, Hillebrand DJ et al. Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 2003; 25: 204-209
18. Gilliet M, Cozzio A, Burg G, Nestle FO. Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporal photopheresis. Br J Dermatol 2005; 152: 531-536
19. Moschella SL, Kay J, Mackool BT, Liu V. Case 35-2004. A 68-year-old man with end stage renal disease and thickening of the skin. N Engl J Med 2004; 351: 2219-2227
20. Vicktor C., Schultz-Ehrenburg U. Papulosis maligna atrophicans (Köhlmeier - Degos) Hautarzt 2001; 52; 734-737
21. Littler CM, Tschen EH. Pentoxifylline for necrobiosis lipoidica diabeticorum. J Am Acad Dermatol 1987; 17: 314-316